Cerritos, CA (February 14, 2018) As featured in Shape magazine, the LANAP protocol is helping to reduce dental patient dependency on opioids. 99.5% of LANAP clinicians have stopped writing prescriptions for opioids post-LANAP surgery and instead prescribe over-the-counter pain relief.
“LANAP surgery has tremendous benefits for patients,” comments Robert H. Gregg II, DDS, president of Millennium Dental Technologies and the inventor of the LANAP® protocol. “The PerioLase MVP-7 was specifically designed with the ideal parameters to effectively treat gum disease following the strict LANAP protocol. The laser energy destroys bacteria and endotoxins; stimulating the body’s natural healing response during the process. By removing scalpels and sutures, we remove the patient’s fear and increase treatment acceptance.”
Studies show 99% of oral surgeons prescribe opioids for wisdom teeth extraction, yet 54% of opioids prescribed are not used. Estimates for opioid prescription are similar for periodontal flap surgery using scalpels and sutures. The LANAP protocol replaces traditional osseous surgery and is the only laser periodontal surgery with scientific evidence supporting the FDA clearance of True Periodontal Regeneration.
“Not only can LANAP treatment regenerate the bone and tissues lost to periodontal disease with virtually no pain, the LAPIP treatment is saving dental implants,” continues Dr Gregg. “We are combating two of dentistry’s biggest challenges – saving ailing and failing implants while achieving the gold standard in Periodontics, that of True Periodontal Regeneration.”
The LANAP protocol is the only laser periodontal protocol validated with two human histological studies and supported with a 6 month money-back clinical results guarantee. LANAP regenerative specialists are required to complete intensive training through the Institute for Advanced Laser Dentistry, including treating three live patients over the course of 12 months.
ABOUT MILLENNIUM DENTAL TECHNOLOGIES, INC.: Millennium Dental Technologies, Inc., is the developer of the LANAP protocol for the treatment of gum disease, the LAPIP protocol for ailing dental implants, and the manufacturer of the PerioLase MVP-7 dental laser. By providing a simple and comfortable experience with unique bone-building clinical results, MDT’s FDA-cleared LANAP protocol removes the fear from gum disease treatment, offering a vastly less painful and less invasive regenerative treatment alternative to conventional surgery. The company’s founding clinician, Robert H. Gregg II, continues to operate the company with the vision: To create better clinical outcomes in periodontal disease patients—remaining true to the guiding principle—”It’s all about the patient.”